Hermetica Superfood Encyclopedia
The Short Answer
Bifidobacterium breve M-16V is a clinically studied probiotic strain that produces short-chain fatty acids and bacteriocins to support gut health. This strain modulates immune responses through Toll-like receptor pathways and enhances intestinal barrier function in infants and adults.
CategoryProbiotic & Fiber
GroupFermented/Probiotic
Evidence LevelStrong
Primary KeywordBifidobacterium breve M-16V benefits
Synergy Pairings5
Bifidobacterium breve M-16V — botanical close-up
Health Benefits
Promotes healthy gut flora in infants and adults, enhancing digestion
- Supports immune system development in early life, reducing infection risk. - Reduces allergy symptoms by modulating immune responses, improving comfort. - Enhances respiratory health by reducing inflammation, promoting easier breathing. - Supports brain health by producing neurotransmitters, enhancing cognitive function. - Aids in weight management by influencing gut hormones, reducing appetite. - Improves skin health by reducing systemic inflammation, promoting a radiant complexion.
Origin & History
Natural habitat
Bifidobacterium breve M-16V is a probiotic strain isolated from human breast milk. It is cultivated in controlled environments to ensure purity and efficacy. This strain is particularly noted for its role in infant gut health.
“Bifidobacterium breve M-16V has been used in Japan and other countries for decades to support infant health and is a staple in many probiotic supplements.”Traditional Medicine
Scientific Research
Clinical trials have shown its efficacy in improving gut health and reducing allergic symptoms in infants. Meta-analyses support its role in immune system development.
Preparation & Dosage
Traditional preparation
Commonly administered in doses of 1-10 billion CFUs per day. Available in powder or capsule form. Consult a healthcare provider before use.
Nutritional Profile
- Produces short-chain fatty acids beneficial for gut health. - High in bifidogenic activity, promoting beneficial bacteria growth. - Contains enzymes that aid in lactose digestion.
How It Works
Mechanism of Action
Bifidobacterium breve M-16V produces acetate and lactate through carbohydrate fermentation, creating an acidic environment that inhibits pathogenic bacteria. The strain activates regulatory T-cells via dendritic cell interaction and TLR2/TLR4 pathways, promoting anti-inflammatory cytokine IL-10 production. It strengthens intestinal barrier function by upregulating tight junction proteins claudin-1 and occludin.
Clinical Evidence
Multiple randomized controlled trials involving over 800 infants have demonstrated M-16V's efficacy in preventing necrotizing enterocolitis and reducing infection rates by 40-60%. A 12-week study with 90 allergic infants showed 35% reduction in eczema severity scores compared to placebo. Respiratory health studies in 200+ children demonstrated 25% fewer upper respiratory infections and reduced inflammatory markers including decreased IL-6 levels. Evidence quality is moderate to high for infant applications, with emerging data for adult benefits.
Safety & Interactions
Bifidobacterium breve M-16V is generally recognized as safe with minimal side effects, occasionally causing mild bloating or gas during initial use. No significant drug interactions have been reported, though immunocompromised patients should consult healthcare providers before use. The strain is considered safe during pregnancy and breastfeeding based on extensive infant safety data. Contraindications include severe acute pancreatitis and central venous catheter presence due to rare bacteremia risk.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Bifidobacterium breve strain M-16VB. breve M-16VBifido M-16VM-16V probiotic strainHuman milk bifidobacteriaInfant bifidus M-16V
Frequently Asked Questions
What is the effective dosage of Bifidobacterium breve M-16V?
Clinical studies typically use doses of 1×10⁹ to 1×10¹⁰ CFU daily for infants and children. Adult dosages range from 1×10¹⁰ to 5×10¹⁰ CFU daily for optimal colonization and therapeutic effects.
How long does it take for Bifidobacterium breve M-16V to work?
Initial gut colonization occurs within 3-7 days of supplementation, with detectable levels in stool samples. Clinical benefits for allergy reduction and immune support typically become apparent after 4-8 weeks of consistent use.
Can Bifidobacterium breve M-16V survive stomach acid?
This strain demonstrates good acid tolerance and can survive gastric transit, with approximately 60-80% viability after exposure to pH 2.0 for 3 hours. Enteric coating or taking with food can further improve survival rates.
Is Bifidobacterium breve M-16V safe for premature infants?
Yes, extensive clinical trials in preterm infants demonstrate safety and efficacy, with studies showing reduced necrotizing enterocolitis risk. The strain is specifically researched for NICU populations and is used in specialized infant formulas.
What makes Bifidobacterium breve M-16V different from other probiotic strains?
M-16V is uniquely adapted to the infant gut microbiome and produces specific exopolysaccharides that enhance mucin production. Unlike generic Bifidobacterium strains, it has documented clinical efficacy in preventing serious infant infections and modulating allergic responses.
Does Bifidobacterium breve M-16V interact with antibiotics or other medications?
Bifidobacterium breve M-16V may be reduced in effectiveness when taken simultaneously with antibiotics, as antibiotics can kill beneficial bacteria along with harmful ones. It is generally recommended to take this probiotic at least 2-3 hours before or after antibiotic doses. If you are taking regular medications, consult your healthcare provider to determine the optimal timing for supplementation.
Who benefits most from supplementing with Bifidobacterium breve M-16V?
Infants and young children benefit significantly from Bifidobacterium breve M-16V, particularly those born vaginally or exclusively breastfed, as this strain naturally colonizes the infant gut. Adults with compromised digestion, frequent infections, allergy symptoms, or respiratory concerns may also experience notable benefits. Those recovering from antibiotic use or with dysbiosis (imbalanced gut flora) are ideal candidates for supplementation.
What does clinical research show about Bifidobacterium breve M-16V's effectiveness?
Clinical studies demonstrate that Bifidobacterium breve M-16V M-16V significantly improves digestive health and reduces colic symptoms in infants within 2-4 weeks of supplementation. Research also supports its role in enhancing immune function and reducing respiratory infections in early childhood populations. Evidence for allergy symptom reduction and cognitive support through GABA and neurotransmitter production is emerging, though further studies are ongoing.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w bifidobacterium-breve-m-16v curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
